Johnson Controls International plc · JCI · FY2025 Q1 · Calendar Q1 2025
Johnson Controls raises outlook as backlog and data centers support growth
The current analysis supports a constructive operating trajectory: Johnson Controls reported stronger organic growth, raised full-year EPS guidance, and cited backlog and data-center demand as visibility and demand supports. The thesis remains conditional on execution through tariff, foreign-exchange, capacity, restructuring, and second-half growth risks.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about JCI FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, guidance sentiment moved from maintained to raised. The current analysis adds a CEO transition, generative-AI capabilities in OpenBlue, stronger order growth, and a larger record backlog, while highlighting tariffs, foreign exchange, and capacity as ongoing concerns.
Guidance delta
Management raised full-year adjusted EPS guidance to $3.50-$3.60 and upgraded its margin outlook; prior-quarter guidance sentiment was maintained.
Key takeaways
- Q1 organic revenue grew 10%, with margin expansion and adjusted EPS of $0.64 above the high end of guidance.
- Record backlog and order growth provide visibility, while data-center cooling, healthcare, and manufacturing remain key demand areas.
- Management highlighted AI-enabled OpenBlue capabilities, higher service attach rates, and a planned CEO transition.
- Tariffs, foreign exchange, restructuring costs, and second-half growth uncertainty remain material risks.
Management priorities
- Scale AI and generative AI capabilities across OpenBlue
- Increase service attach rates and product-service integration
- Complete the residential and light-commercial divestiture
- Return 100% of free cash flow through dividends and share repurchases
- Advance cost reduction and restructuring initiatives
Follow JCI with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 18, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Neutral | Neutral | Maintain | Oct 15, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 14, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 12, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Aug 14, 2026 |
| UBS | Buy | Buy | Maintain | Jun 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 7, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 6, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 7, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 7, 2025 |
| Jefferies | Hold | Buy | Downgrade | Jul 24, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Jun 20, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | May 12, 2025 |
| Melius Research | Hold | Buy | Downgrade | Jan 28, 2025 |
| HSBC | Hold | Buy | Downgrade | Jan 31, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Dec 13, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 4, 2022 |
| OTR Global | Positive | Mixed | Upgrade | Apr 27, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Dec 9, 2020 |
| CFRA | Buy | Buy | Maintain | May 1, 2020 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 9, 2020 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Feb 19, 2019 |
| Argus | Buy | Hold | Upgrade | Aug 21, 2018 |
| Susquehanna | Neutral | Positive | Downgrade | Nov 15, 2017 |
| Vertical Group | Hold | Buy | Downgrade | Nov 10, 2017 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 23, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Sep 8, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 2, 2015 |
| Nomura | Buy | Buy | Maintain | Oct 2, 2015 |
| Ascendiant Capital | Buy | Buy | Maintain | Dec 23, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Feb 19, 2014 |
| Lazard | Buy | Neutral | Upgrade | May 13, 2013 |
| Credit Agricole | Buy | Outperform | Maintain | Mar 14, 2013 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 1, 2012 |
| Stifel | Buy | Buy | Maintain | Nov 1, 2012 |
| Needham | Hold | Buy | Downgrade | Nov 1, 2012 |
| Sterne Agee | Neutral | Neutral | Maintain | Jul 24, 2012 |
| Bank of America | Buy | Buy | Maintain | Jul 19, 2012 |
| Wunderlich Securities | Buy | Buy | Maintain | Jul 6, 2012 |
| Wunderlich | Buy | Buy | Maintain | Jul 6, 2012 |
| Guggenheim | Buy | Buy | Maintain | Mar 7, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $145.47. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $165 | $152.44 | +13.4% | Oct 15, 2026 |
| Wells Fargo | Analyst unavailable | $186 | $145.36 | +27.9% | Sep 24, 2026 |
| Morgan Stanley | Analyst unavailable | $180 | $138.46 | +23.7% | Sep 2, 2026 |
| Bernstein | Analyst unavailable | $190 | $152.36 | +30.6% | Aug 14, 2026 |
| Argus Research | John Eade | $175 | $154.55 | +20.3% | Aug 7, 2026 |
| Bernstein | Analyst unavailable | $176 | $147.75 | +21.0% | Jun 9, 2026 |
| Morgan Stanley | Chris Snyder | $175 | $144.05 | +20.3% | Jun 9, 2026 |
| Wolfe Research | Analyst unavailable | $171 | $141.99 | +17.6% | Jun 3, 2026 |
| UBS | Amit Mehrotra | $180 | $141.26 | +23.7% | Jun 2, 2026 |
| RBC Capital | Analyst unavailable | $154 | $139.12 | +5.9% | May 7, 2026 |
| Barclays | Julian Mitchell | $144 | $143.14 | -1.0% | May 7, 2026 |
| Morgan Stanley | Christopher Snyder | $140 | $134.99 | -3.8% | Mar 11, 2026 |
| RBC Capital | Deane Dray | $140 | $131.97 | -3.8% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $130 | $131.39 | -10.6% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $154 | $129.49 | +5.9% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $132 | $129.49 | -9.3% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $136 | $129.49 | -6.5% | Feb 5, 2026 |
| Morgan Stanley | Analyst unavailable | $130 | $111.51 | -10.6% | Jan 13, 2026 |
| Melius Research | Scott Davis | $148 | $113.95 | +1.7% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $125 | $113.95 | -14.1% | Jan 7, 2026 |
| Goldman Sachs | Analyst unavailable | $142 | $122.25 | -2.4% | Nov 6, 2025 |
| UBS | Amit Mehrotra | $124 | $123 | -14.8% | Nov 6, 2025 |
| Barclays | Julian Mitchell | $90 | $95.28 | -38.1% | May 14, 2025 |
| Wells Fargo | Joe O’Dea | $100 | $91.68 | -31.3% | May 8, 2025 |
| Barclays | Analyst unavailable | $85 | $80.07 | -41.6% | Mar 10, 2025 |
| Wells Fargo | Joesph O'Dea | $92 | $79.17 | -36.8% | Jan 7, 2025 |
| Argus Research | John Eade | $88 | $79.25 | -39.5% | Dec 20, 2024 |
| Bank of America Securities | Andrew Obin | $80 | $68.6 | -45.0% | Sep 10, 2024 |
| Morgan Stanley | Chris Snyder | $85 | $69.38 | -41.6% | Sep 6, 2024 |
| RBC Capital | Sector Perform | $69 | $67.82 | -52.6% | Aug 14, 2024 |
| RBC Capital | Deane Dray | $61 | $71.03 | -58.1% | Aug 1, 2024 |
| Barclays | Julian Mitchell | $62 | $68.19 | -57.4% | Jun 21, 2024 |
| Barclays | Julian Mitchell | $61 | $65.13 | -58.1% | Apr 2, 2024 |
| Citigroup | Andrew Kaplowitz | $58 | $56.08 | -60.1% | Dec 11, 2023 |
| Morgan Stanley | Joshua Pokrzywinski | $73 | $58.51 | -49.8% | May 5, 2023 |
| Oppenheimer | Analyst unavailable | $72 | $66.36 | -50.5% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $72 | $65.02 | -50.5% | Jan 5, 2023 |
| Barclays | Analyst unavailable | $75 | $65.65 | -48.4% | Jan 5, 2023 |
| Citigroup | Analyst unavailable | $68 | $65.77 | -53.3% | Dec 9, 2022 |
| Deutsche Bank | Analyst unavailable | $74 | $66.98 | -49.1% | Dec 5, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $67.63 | -51.9% | Dec 2, 2022 |
| Morgan Stanley | Analyst unavailable | $62 | $54.89 | -57.4% | Sep 1, 2022 |
| Morgan Stanley | Analyst unavailable | $61 | $55.53 | -58.1% | Aug 8, 2022 |
| Oppenheimer | Analyst unavailable | $63 | $55.1 | -56.7% | Aug 8, 2022 |
| Jefferies | Stephen Volkmann | $65 | $50.34 | -55.3% | Jul 26, 2022 |
| Mizuho Securities | Analyst unavailable | $65 | $47.03 | -55.3% | Jul 18, 2022 |
| Barclays | Analyst unavailable | $60 | $47.67 | -58.8% | Jul 8, 2022 |
| Morgan Stanley | Analyst unavailable | $54 | $47.82 | -62.9% | Jul 7, 2022 |
| Wells Fargo | Analyst unavailable | $60 | $48.44 | -58.8% | Jun 29, 2022 |
| Goldman Sachs | Analyst unavailable | $62 | $47.44 | -57.4% | Jun 23, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $59 | $55 | -59.4% | Jun 7, 2022 |
| Barclays | Analyst unavailable | $65 | $50.89 | -55.3% | May 24, 2022 |
| RBC Capital | Analyst unavailable | $61 | $54.59 | -58.1% | May 5, 2022 |
| Credit Suisse | John Walsh | $73 | $54.83 | -49.8% | May 5, 2022 |
| Morgan Stanley | Analyst unavailable | $71 | $54.84 | -51.2% | May 5, 2022 |
| Barclays | Julian Mitchell | $80 | $66.2 | -45.0% | Apr 5, 2022 |
| Mizuho Securities | Brett Linzey | $88 | $68.88 | -39.5% | Feb 3, 2022 |
| Jefferies | Stephen Volkmann | $90 | $73.39 | -38.1% | Jan 24, 2022 |
| Cowen & Co. | Gautam Khanna | $86 | $80.87 | -40.9% | Dec 31, 2021 |
| UBS | Markus Mittermaier | $92 | $77.03 | -36.8% | Dec 14, 2021 |
| Citigroup | Andrew Kaplowitz | $81 | $73.75 | -44.3% | Nov 8, 2021 |
| Oppenheimer | Noah Kaye | $86 | $74.62 | -40.9% | Sep 9, 2021 |
| HSBC | Puneet Garg | $66 | $70.41 | -54.6% | Aug 4, 2021 |
| Wolfe Research | Nigel Coe | $83 | $69.75 | -42.9% | Jul 12, 2021 |
| Goldman Sachs | Joe Ritchie | $83 | $67.72 | -42.9% | Jun 30, 2021 |
| Argus Research | John Eade | $72 | $63.75 | -50.5% | May 6, 2021 |
Track every rating change on JCI the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationJohnson Controls International plc, together with its subsidiaries, engages in engineering, manufacturing, commissioning, and retrofitting building products and systems in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company designs, manufactures, sells, installs, and services heating, ventilating, air conditioning, controls, building management, refrigeration, integrated electronic security, integrated fire detection and suppression systems, and digital solutions. It also provides energy solutions and technical services, including inspection, scheduled maintenance, and repair and replacement of mechanical and control systems, as well as data-driven building solutions. It sells its products and services to commercial, residential security, institutional, industrial, data center, marine, and governmental customers. Johnson Controls International plc was incorporated in 1885 and is based in Cork, Ireland.
Historical context
All JCI earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AA Alcoa Corporation | FY2026 Q3 · Calendar Q4 2026 | +20.5% | +7.2% | Alcoa: Strong Q3 execution, with safety and transaction risks ahead |
Latest beats and misses
Who reports nextBeat on EPS
Get the JCI recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-22T00:04:22.296664+00:00
- Polygon adjusted daily market bars · 2026-10-18T12:20:40.970867+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T12:20:40.968100+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.